(Q43796854)

26 November 2017

title

Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation (English)

1 reference

26 November 2017

1 reference

18

1 reference

26 November 2017

Kanda Y

1

1 reference

26 November 2017

Mineishi S

2

1 reference

26 November 2017

Saito T

3

1 reference

26 November 2017

Saito A

4

1 reference

26 November 2017

Yamada S

5

1 reference

26 November 2017

Ohnishi M

6

1 reference

26 November 2017

Chizuka A

7

1 reference

26 November 2017

Niiya H

8

1 reference

26 November 2017

Suenaga K

9

1 reference

26 November 2017

Nakai K

10

1 reference

26 November 2017

Takeuchi T

11

1 reference

26 November 2017

Makimoto A

12

1 reference

26 November 2017

Tanosaki R

13

1 reference

26 November 2017

Kami M

14

1 reference

26 November 2017

Tanaka Y

15

1 reference

26 November 2017

Fujita S

16

1 reference

26 November 2017

Watanabe T

17

1 reference

26 November 2017

Tobinai K

19

1 reference

26 November 2017

Takaue Y

20

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

Bone Marrow Transplantation

26 November 2017

published in

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

689-692

1 reference

Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

Subclinical Varicella-Zoster Virus Viremia, Herpes Zoster, and T Lymphocyte Immunity to Varicella-Zoster Viral Antigens after Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

Induction of acyclovir-resistant mutants of herpes simplex virus type I in athymic nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703214

21 January 2018

Identifiers

DOI

10.1038/SJ.BMT.1703214

1 reference

Dimensions Publication ID

26 November 2017

1001378806

0 references

1 reference